American Portfolios Advisors’s Alterity Therapeutics ATHE Stock Holding History

American Portfolios Advisors’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8	Closed	-$105	–	3515
2021 Q3	$105	Hold	8	–	–	﹤0.01%	3441
2021 Q2	$108	Hold	8	–	–	﹤0.01%	3373
2021 Q1	$120	Hold	8	–	–	﹤0.01%	3249
2020 Q4	$111	Hold	8	–	–	﹤0.01%	2948
2020 Q3	$168	Hold	8	–	–	﹤0.01%	2906
2020 Q2	$99	Hold	8	–	–	﹤0.01%	2822
2020 Q1	$50	Hold	8	–	–	﹤0.01%	2755
2019 Q4	$65	Hold	8	–	–	﹤0.01%	2807
2019 Q3	$95	Hold	8	–	–	﹤0.01%	2788
2019 Q2	$109	Hold	8	–	–	﹤0.01%	2699
2019 Q1	$156	Hold	8	–	–	﹤0.01%	2572
2018 Q4	$106	Hold	8	–	–	﹤0.01%	2365
2018 Q3	$167	Hold	8	–	–	﹤0.01%	2375
2018 Q2	$157	Hold	8	–	–	﹤0.01%	2345
2018 Q1	$177	Hold	8	–	–	﹤0.01%	2271
2017 Q4	$259	Buy	+8	New	+$251	﹤0.01%	2220

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

PCA

Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return

American Portfolios Advisors's ATHE Position: Q4 2021 in Review

American Portfolios Advisors sold out of Alterity Therapeutics (ATHE) in Q4 2021, closing a stake of 8 shares — an estimated $105 sold.

American Portfolios Advisors first reported a position in ATHE in Q4 2017 and held it in 16 quarters. The position peaked at $259 in Q4 2017. 11 funds tracked by Wall St. Rank hold ATHE as of Q4 2021.

American Portfolios Advisors reported no remaining Alterity Therapeutics position as of Q4 2021 after selling out during the quarter.
American Portfolios Advisors sold 8 Alterity Therapeutics shares in Q4 2021, an estimated $105.
American Portfolios Advisors first reported a position in Alterity Therapeutics in Q4 2017 and held it in 16 quarters.
American Portfolios Advisors's Alterity Therapeutics position peaked at $259 in Q4 2017.
11 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2021.

Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.